Last reviewed · How we verify
NCT07170774
Research on the Enhancement of Aerobic Metabolic Energy Supply Capacity by Ischemic Preconditioning.
NA trial testing Ischemic Preconditioning in Ischemic Preconditioning in 16 participants. Completed in 1 June 2024.
1 June 2024
Quick facts
| Lead sponsor | Ziyue Ou |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | other |
| Enrollment | 16 |
| Start date | 1 April 2024 |
| Primary completion | 1 June 2024 |
| Estimated completion | 1 June 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Ischemic Preconditioning — full drug profile →
- Sham
Conditions studied
- Ischemic Preconditioning — all drugs for Ischemic Preconditioning →
- Aerobic Capacity — all drugs for Aerobic Capacity →
Sponsor
Ziyue Ou
Who can join
Adults 18 to 22, male only, with Ischemic Preconditioning or Aerobic Capacity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this clinical trial is to investigate whether IPC can improve aerobic capacity during exercise. The primary question it aims to answer is: Does IPC enhance the aerobic capacity of athletes? The researchers will compare IPC (220 mmHg pressure) with a placebo (20 mmHg pressure) to see if different interventions can enhance aerobic capacity and exercise performance. Participants will: * Undergo a randomized crossover controlled trial, visiting twice, with a one-week interval between each test. * Conduct two assessments at the testing site each time, namely a pre-intervention assessment and a post-intervention assessment. * Record their heart rate, blood pressure, weight, oxygen uptake, Taekwondo-specific performance, and other indicators.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ischemic preconditioning enhances energy supply during frequency speed kick test in Taekwondo athletes: A randomized crossover study.
Ou Z, Yang L, Xie D, Zhu H, et al · · 2026 · PMID 41632764 · DOI 10.1371/journal.pone.0341780
Verify or expand the search:
- PubMed search for NCT07170774
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ischemic Preconditioning
Trials testing the same drug.
- NCT07003113 — Ischemic Preconditioning in Osteoarthritis and Back Pain · NA · recruiting
- NCT07497659 — Ischemic Preconditioning in Resistance Exercise in Older Women · NA · completed
- NCT07117643 — Ischemic Preconditioning - Perspectives of Use Vivio/in Vitro Studies · NA · enrolling by invitation
- NCT05929508 — Improving Mobility and Function Following Transfemoral Amputation: A Novel Approach to Reverse Volumetric Muscle Loss · NA · recruiting
- NCT07146399 — The Impact of Ischemic Preconditioning on Exercise Performance and Physiological Function · NA · completed
Other recruiting trials for Ischemic Preconditioning
Currently open trials in the same condition.
- NCT05957523 — Effects of Remote Ischemic Preconditioning on Peripheral Blood Biomarkers in Healthy Adults (EMINENT) · NA · recruiting
Other Ziyue Ou trials
Trials by the same sponsor.
- NCT07146399 — The Impact of Ischemic Preconditioning on Exercise Performance and Physiological Function · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07170774 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ziyue Ou
- Last refreshed: 12 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07170774.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing